Skip to search formSkip to main contentSkip to account menu

hu1124

Known as: Hu 1124 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2005
Review
2005
OBJECTIVE: To review the pharmacology, efficacy, and safety of efalizumab for the treatment of moderate to severe plaque… 
Highly Cited
2004
Highly Cited
2004
The pharmacokinetics of hu1124, a human anti-CD11a antibody, were investigated in human subjects with psoriasis. CD11a is a… 
Highly Cited
2001
Highly Cited
2001
BACKGROUND Anti-CD11a (hu1124) is a humanized monoclonal antibody directed against the CD11a subunit of LFA-1. This study… 
Review
2001
Review
2001
  • F. Vincenti
  • Transplantation proceedings
  • 2001
  • Corpus ID: 1007713
Highly Cited
2000
2000
2000
  • H. Granlund
  • IDrugs : the investigational drugs journal
  • 2000
  • Corpus ID: 10234921
Genentech and XOMA are collaborating in the development of a humanized monoclonal antibody, hu1124 (anti-CD11a), which has the… 
2000
2000
  • 2000
  • Corpus ID: 195131707